top of page

Colombianos Londres Group

Public·14 members
Meechie Chow
Meechie Chow

Episode 5.17 Torrent



Sydney is depicted in the series as being strong both physically and emotionally. She deals with some significant trauma over the years: the death of her fiancé, the death of her best friend, the realization that her mother was a former KGB spy, the estrangement of many of her friends and the constant activity and changes that she must endure from being a spy on a regular basis. Sydney is highly skilled in Krav Maga and is a polyglot, speaking English, Russian, German, Greek, Dutch, French, Italian, Spanish, Portuguese, Norwegian, Swedish, Romanian, Hungarian, Hebrew, Uzbek, Arabic, Persian, Urdu, Indonesian, Cantonese, Mandarin, Japanese, Korean, Hindi, Vietnamese, Polish, Serbian, Czech, Ukrainian, and Bulgarian in various episodes. Throughout the series her code names are Bluebird, Freelancer, Mountaineer, and Phoenix.




Episode 5.17 Torrent


Download Zip: https://www.google.com/url?q=https%3A%2F%2Ftinourl.com%2F2u51VW&sa=D&sntz=1&usg=AOvVaw0nFqN5lhlvVCGYE5UMSQ7i



Season 2 saw a fundamental change in Sydney's character, allegedly introduced in order to give the show more action. In the first season, Sydney almost never kills, preferring fisticuffs and tranquilizer guns to deadly blows and real bullets. Starting this season, she behaves more like a stereotypical spy, usually killing enemies and rarely using tranq guns. Although there were some minor incidents prior, the episode "Phase One" is generally considered to mark the arrival of this new version of Sydney. While some fans have criticized this change in Sydney's character, others have suggested that it might have been influenced by the arrival of her mother. During season 2 Sydney also begins to dress and act more sexually to achieve her goals.


Sydney continues to go on missions when her condition allows, often using the pregnancy as part of her disguises. However, in the episode "Solo", she came to realize that these days might be fast coming to a (temporary) end when she is not allowed to go on a mission due to her condition.


The team next tracks Sloane to Mongolia and the tomb of Milo Rambaldi. There Sydney encounters Sloane yet again as he implements his endgame by placing the Horizon on an altar, thus creating a red, hovering ball-shaped fluid similar to that created by the Mueller device. Sydney disrupts Sloane's plans by grabbing the Horizon from the altar, causing the ball to collapse in a torrent of red liquid. Sark leads Jack and Vaughn into the tomb after capturing them, and Sloane shoots Jack in the chest to force Sydney and Vaughn to leave. Seeing her father severely wounded, Sydney grabs a gun and eventually shoots Sloane several times, who crashes into the puddle of Rambaldi-fluid. With Sloane seemingly dead, Sydney tries to stay with her bleeding father, but he begs her to leave him and to stop Irina. Sydney reluctantly obeys and departs for Hong Kong for a final confrontation with Irina. Jack drags himself back into the tomb and confronts Sloane, who has become immortal because of the fluid. Sloane offers to heal Jack, but Jack tells Sloane that he has caused so much pain for Sydney over the years that he will not allow him to do it again and reveals a bomb that he strapped to his body and detonates it, killing himself. The explosion causes a cave in and Sloane is trapped in there forever.


Creator Fogelman announced years ago that Season 6 would be the final chapter of the award-winning TV series, saying he wanted it to go out on his own terms. The sixth season premiered on Tuesday, January 4, 2022 and aired a total of 18 episodes, the same number as each of the first four seasons. The only exception was Season 5, which produced just 16 episodes due to delays brought about by the Covid-19 pandemic.


"The Price of Magic"SpecialSeason aired: TwoEpisode InformationPremiere date:April 14, 2013Viewers:5.17 million[1]Hosted by:Edward KitsisAdam HorowitzNarrated by:Alan DaleWritten by:Steve MulhollandRelated PagesTRANSCRIPT


While there is no body of evidence to answer the question of how long a patient treated with olanzapine and fluoxetine in combination should remain on it, it is generally accepted that bipolar I disorder, including the depressive episodes associated with bipolar I disorder, is a chronic illness requiring chronic treatment. The healthcare provider should periodically reexamine the need for continued pharmacotherapy.


While there is no body of evidence to answer the question of how long a patient treated with olanzapine and fluoxetine in combination should remain on it, it is generally accepted that treatment resistant depression (major depressive disorder in adult patients who do not respond to 2 separate trials of different antidepressants of adequate dose and duration in the current episode) is a chronic illness requiring chronic treatment. The healthcare provider should periodically reexamine the need for continued pharmacotherapy.


Olanzapine monotherapy is not indicated for treatment of treatment resistant depression (major depressive disorder in patients who do not respond to 2 antidepressants of adequate dose and duration in the current episode).


In placebo-controlled olanzapine monotherapy studies in adolescent patients (up to 6 weeks) with schizophrenia or bipolar I disorder (manic or mixed episodes), changes from normal to high in prolactin concentrations were observed in 47% of olanzapine-treated patients compared to 7% of placebo-treated patients. In a pooled analysis from clinical trials including 454 adolescents treated with olanzapine, potentially associated clinical manifestations included menstrual-related events 1 (1% [2/168] of females), sexual function-related events 2 (0.7% [3/454] of females and males), and breast-related events 3 (2% [3/168] of females, 2% [7/286] of males) [see Use in Specific Populations ( 8.4)].


The information below for olanzapine is derived from a clinical trial database for olanzapine consisting of 10,504 adult patients with approximately 4,765 patient-years of exposure to olanzapine. This database includes: (1) 2,500 patients who participated in multiple-dose oral olanzapine premarketing trials in schizophrenia and Alzheimer's disease representing approximately 1,122 patient-years of exposure as of February 14, 1995; (2) 182 patients who participated in oral olanzapine premarketing bipolar I disorder (manic or mixed episodes) trials representing approximately 66 patient-years of exposure; (3) 191 patients who participated in an oral olanzapine trial of patients having various psychiatric symptoms in association with Alzheimer's disease representing approximately 29 patient-years of exposure; (4) 5,788 additional patients from 88 oral olanzapine clinical trials as of December 31, 2001; (5) 1,843 additional patients from 41 olanzapine clinical trials as of October 31, 2011. Also included below is information from the premarketing 6-week clinical study database for olanzapine in combination with lithium or valproate, consisting of 224 patients who participated in bipolar I disorder (manic or mixed episodes) trials with approximately 22 patient-years of exposure.


Certain portions of the discussion below relating to objective or numeric safety parameters, namely, dose-dependent adverse reactions, vital sign changes, weight gain, laboratory changes, and ECG changes are derived from studies in patients with schizophrenia and have not been duplicated for bipolar I disorder (manic or mixed episodes) or agitation. However, this information is also generally applicable to bipolar I disorder (manic or mixed episodes) and agitation.


The following findings are based on premarketing trials of oral olanzapine for schizophrenia, bipolar I disorder (manic or mixed episodes), a subsequent trial of patients having various psychiatric symptoms in association with Alzheimer's disease, and premarketing combination trials.


Safety and efficacy of olanzapine and fluoxetine in combination in children and adolescents (10 to 17 years of age) have been established for the acute treatment of depressive episodes associated with bipolar I disorder.


In this flexible-dose trial, olanzapine 2.5 to 20 mg/day (mean modal dose 10.7 mg/day, mean dose of 8.9 mg/day) was more effective than placebo in the treatment of adolescents with manic or mixed episodes associated with bipolar I disorder, as supported by the statistically significantly greater mean reduction in Y-MRS total score for patients in the olanzapine treatment group than in the placebo group.


This add-on features Trakt support, library integration, file downloads, subtitles, cloud storage manager, continuous episode playback and more. It uses a new provider package called CocoScrapers, which is also used by Fen, another great add-on for Kodi.


When playing an episode, the add-on will automatically select a source according to the Sorting and Filter settings. Episodes will play continuously and the Play Next/Still Watching dialogs will be displayed at the end of each episode.


Japanese staffJapanese castDirector: Masato JinboSeries Composition: Masato JinboScript: Masato Jinbo (eps 1-12)Storyboard:Hideaki Oba (ep 10)Jouji Shimura (ep 2)Ken'ichi Nishida (eps 3, 8)Masakatsu Iijima (ep 9)Masato Jinbo (OP; ep 12)Mayu Hirotomi (ep 4)Norio Nitta (eps 1, 5, 11)Sayaka Yamai (ep 6)Takahiro Hirata (ep 4)Tomoko Akiyama (ED; ep 7)Episode Director:Akihiko Ota (ep 9)Hideaki Oba (ep 10)Hideki Takeda (ep 6)Ken'ichi Nishida (eps 3, 8)Mayu Numayama (eps 2, 7)Norio Nitta (ep 1)Sayaka Yamai (eps 5, 11)Takahiro Hirata (eps 4, 12)Unit Director:Jouji Shimura (ED)Masato Jinbo (OP)Music:Miho TsujibayashiTOMISIROOriginal creator: Junpei InuzukaOriginal Character Design: Katsumi EnamiCharacter Design: Yasukazu ShojiArt Director: Kenji KatoChief Animation Director:Hitomi Kōno (eps 5-6, 8, 10)Mai Kuwabara (5 episodeseps 3, 6-7, 11-12)Shinobu Ookawa (ep 3)Taka Sato (6 episodeseps 2, 6, 8-9, 11-12)Yasukazu Shoji (eps 4-8, 12)Animation Director:Aki Yamagata (eps 3, 8, 11)Aoi Yamato (eps 4, 7)Hiromi Nakayama (OP; eps 4, 7)Hitomi Kōno (eps 1, 5)Kanae Komatsu (ep 9)Katsuji Matsumoto (ep 6)Kazuyuki Toshida (eps 3, 8, 11)Mai Kuwabara (ep 1)Masaaki Sakurai (ep 9)Miki Nomura (ep 6)Miyo Ōno (4 episodeseps 2, 5, 10, 12)Pei Qi Peng (ep 9)Reiko Arai (ep 6)Shi Ming Fu (ep 9)Shinobu Ookawa (OP,ED)Tetsurō Taira (eps 2, 7, 12)Wan Qian Xie (ep 9)Yasukazu Shoji (OP; ep 12)Yukie Kinoshita (eps 10, 12)Yumenosuke Tokuda (ep 9)Yuri Abe (OP; 4 episodeseps 4, 7, 10, 12)Sound Director: Masanori TsuchiyaDirector of Photography: Atsushi SatōProducer:Akihiko OkadaAoi TaniguchiAya IizukaHideki KamaKento YoshidaMirai Yamauchi (TV Tokyo)Motoo KawabataNobuhiko KurosuShousei ItoShūichi MotohashiSôji Miyagi2nd Key Animation:Akane Miyazawa (ep 4)Akihiro Ōtake (ep 12)Akihito Aoki (ep 11)Akiko Kashō (eps 2-3, 5, 8)Chisato Ikehira (ep 11)Dan Jun Dong (ep 9)Dong Dong Liu (ep 9)Emi Mori (eps 7-8, 10)Eri Ueda (ep 5)Eru Saida (ep 5)Feng Liu (ep 9)Haruko Higashida (ep 2)Jun Miki (5 episodeseps 1, 4-5, 10, 12)Kumiko Tanihira (ED; eps 2-3, 7-8)Lan Xi Liu (6 episodeseps 2-3, 5, 7, 10, 12)Makoto Murata (ep 1)Mari Toyoda (ep 11)Megumi Ueda (ED)Ming Feng Yue (ep 9)Rina Oota (ED)Rion Matsuda (ep 1)Risa Yoshida (ep 5)Ryōka Moriyama (eps 1-3)Saki Noguchi (eps 1, 3)Sayaka Yamai (eps 2-3)Shinji Matsuda (ED)Shu Yin Gong (ep 9)Taeko Igo (eps 1-2)Tatsuya Ogawa (eps 8, 10, 12)Ting Ting Zhou (ep 9)Wei Feng Li (ep 9)Xue Wu Xu (ep 9)Yasukazu Kikuchi (eps 5, 12)Yong Ping Huang (ep 9)Yuki Hijikata (eps 7-8)Yuki Nakamura (ep 8)Yukino Yasui (eps 4-5, 8)Yūko Suzuki (eps 2, 7, 10-12)Yūma Yokomatsu (ep 11)Animation producer: Daisuke YoshiokaAssociate producer:Eiji KanaokaFujiko KashiwadaFumihiro OzawaKento TanakaMomoyo TsubakimotoShuka NishimaeTakuma SugiBackground Art:Ami Shimomura (Studio Pinewood; eps 1-12)Chisayo Namai (Studio Pinewood; eps 1-12)Junko Matsui (Studio Pinewood; eps 1-12)Miyuki Sugita (Studio Pinewood; eps 1-12)Takahiro Terauchi (Studio Pinewood; eps 1-12)Tomoki Moriya (Studio Pinewood; eps 1-12)Tomoko Sekiya (Studio Pinewood; eps 1-12)Yū Tachimoto (Studio Pinewood; eps 1-12)CG Art:Chihiro SuzukiKatsuki TakaoMinayo ShimodaCG Design:Dai SeoNaoto IshidaShōta HiranoTetsuya NomuraColor Coordination:Ai Shiga (ep 9)Emiko Tate (ep 11)Kumiko Akahori (eps 1, 4, 6, 8)Naomichi Hata (4 episodeseps 3, 7, 10, 12)Shūya Yoshisato (eps 2, 5)Color design: Tatsue OhzekiCooking Animation Director: Shinobu Ookawa (eps 1-12)Cooking Color Design:Kumiko Akahori (ep 2)Nao Sato (eps 3-12)Editing: Mayumi KomoriFinish Animation:Akiyuki Hatanaka (Studio Targe; ep 6)Bo Gao (Akatsuki & Phoenix Holdings; ep 9)Cheng Dai (Akatsuki & Phoenix Holdings; ep 9)Emiko Tate (ep 11)Hisashi Koyanagi (Studio Targe; ep 6)Li Jun Zhou (Akatsuki & Phoenix Holdings; ep 9)Meng Qin Peng (Akatsuki & Phoenix Holdings; ep 9)Naoko Miyahara (Studio Targe; ep 6)Qi Zhou (Akatsuki & Phoenix Holdings; ep 9)Qing Feng Ren (Akatsuki & Phoenix Holdings; ep 9)Ryusuke Minami (Studio Targe; ep 6)Sheng Hua Shao (Akatsuki & Phoenix Holdings; ep 9)Wei Zhu Gong (Akatsuki & Phoenix Holdings; ep 9)Xing Yue Xie (Akatsuki & Phoenix Holdings; ep 9)Yōko Ikeda (Studio Targe; ep 6)Yuko Minowa (Studio Targe; ep 6)Finish Check:Ai Shiga (ep 9)Emiko Tate (ep 11)Kumiko Akahori (eps 1, 4, 6, 8)Naomichi Hata (4 episodeseps 3, 7, 10, 12)Shūya Yoshisato (eps 2, 5)In-Between Animation:Aoi Maekawa (eps 2-5, 7)Asuka Nagata (7 episodeseps 2-5, 7-8, 10)Chao Xu (Akatsuki & Phoenix Holdings; ep 9)Chihiro Henmi (eps 2-4, 7)Emari Morita (eps 2-5, 8, 10)Feng Feng Lian (Akatsuki & Phoenix Holdings; ep 9)Haruka Itakura (eps 2, 4, 7)Haruto Murata (eps 2-5, 7-8)Hina Sasaki (7 episodeseps 2-5, 7-8, 11)Hiromi Itō (eps 2, 4, 7-8)Hong Jia (Akatsuki & Phoenix Holdings; ep 9)Hui Yue (Akatsuki & Phoenix Holdings; ep 9)Jie Qian (Akatsuki & Phoenix Holdings; ep 9)Jin Hao Zhang (Akatsuki & Phoenix Holdings; ep 9)Kana Fujishiro (6 episodeseps 1-2, 4-5, 7-8)Kanami Kawanishi (eps 2, 4-5, 7)Kei Goda (eps 2-5, 7-8)Mai Ikeuchi (eps 2-4, 7)Marie Tomizuka (eps 2-4)Masayo Okuzumi (eps 2-4, 8, 11)Meng Yuan Hua (Akatsuki & Phoenix Holdings; ep 9)Miho Kawasaki (7 episodeseps 2-5, 7-8, 11)Mika Kimura (eps 1-5, 7)Mika Sugawara (eps 2-5, 7-8)Min Zhao (Akatsuki & Phoenix Holdings; ep 9)Misaki Saitō (5 episodeseps 1, 3-4, 8, 12)Momoko Kifune (eps 2-4, 7)Nagisa Zaizen (eps 2, 4)Naho Harada (8 episodeseps 1-5, 7-8, 12)Qing Feng (Akatsuki & Phoenix Holdings; ep 9)Riho Itō (9 episodeseps 2-5, 7-8, 10-12)Shiomi Yano (eps 1-5, 7, 11)Xiao Hua Zhou (Akatsuki & Phoenix Holdings; ep 9)Yi Su (Akatsuki & Phoenix Holdings; ep 9)Yorihiro Tanimoto (7 episodeseps 1-3, 5, 7-8, 11)Yuki Saitō (eps 2-4, 7-8)Yumi Abe (7 episodeseps 2-5, 7, 10, 12)In-Between Check:Marie Tomizuka (eps 2, 4)Mina Shimada (ep 9)Misaki Saitō (5 episodeseps 1, 3, 5, 8, 11)Yumi Abe (eps 7, 10, 12)Key Animation:Aaya Yoshida (eps 8, 11)Akane Hirota (ep 7)Aki Yamagata (eps 1, 3)Akiko Shimura (ED)Akira Koremoto (ep 11)Ako Kagiyama (eps 3, 10)Aoi Yamato (ep 4)Ayu Tanaka (OP)Ayumi Namiki (eps 1, 5, 8, 10)Ayumi Ueno (eps 1, 3, 7, 11)Azusa Yada (ep 11)Chen Jun Jiang (ep 9)Chieko Hisha (eps 1, 5, 8, 11)Chisato Ikehira (OP; eps 2, 4, 7)Eikichi Takahashi (OP; 7 episodeseps 1-7 odd, 8, 10, 12)Emi Mori (eps 1, 3, 5, 12)Eri Ueda (eps 3, 10)Haruhiko Noda (5 episodeseps 1, 3-4, 7, 10)Haruko Higashida (ep 12)Hikaru Uchiyama (eps 2, 5, 12)Hiromi Nakayama (eps 1, 4)Hiroshi Mimata (ep 12)Jouji Shimura (ED)Kaede Mashiro (ep 9)Katsuji Matsumoto (eps 4, 8, 11-12)Kawara Andō (ep 5)Kazumasa Takeuchi (ep 3)Kazuyuki Toshida (eps 1, 3)Ke Yi Jin (ep 9)Kimiharu Obata (ep 7)Kimiyo Nakamura (ep 9)Kōji Nobuhara (ep 9)Kōsaku Taniguchi (ep 8)Kumiko Kakoi (ep 5)Kuniko Hamano (eps 3, 7, 10)Kurika Yamagata (ep 12)Makoto Murata (OP; eps 4, 7, 11)Mao Torii (eps 2, 6)Mari Toyoda (eps 1, 4, 8, 12)Mariko Shimamura (eps 2, 5, 12)Marina Kasai (ep 6)Masaki Tamakoshi (eps 3, 7, 10)Masanao Okubo (ep 12)Mayumi Yamamoto (eps 2, 4, 8)Megumi Ueda (eps 10, 12)Michiko Notsu (ep 10)Min Wang (ep 9)Mineko Yagihara (ep 4)Ming Zhe Qiu (ep 11)Mitsuki Kosaka (eps 3, 12)Miyako Ōta (ep 12)Miyo Ōno (ep 2)Mizuho Tajima (eps 4, 8)Natsumi Tomobe (eps 7, 11)Nozomi Ishii (eps 3, 8, 10)Nozomi Uchihi (ep 6)Rieko Akasaka (ep 11)Rieko Noguchi (eps 2, 5)Rumi Sudō (ep 9)Sae Ishizuka (eps 1, 5, 8, 12)Seren Ogura (eps 2, 5, 12)Setsuko Unno (eps 3, 7)Shi Ming Fu (ep 9)Shigeki Awai (ep 9)Shirou Tamashiro (ep 3)Shizuko Minami (ep 6)Tae Motodate (ED; eps 2, 6)Taichi Nakaguma (ED)Takashi Hirabayashi (ep 1)Tatsuya Annoura (eps 2, 4, 8, 11)Tetsuya Sunaga (eps 1, 4, 8, 11)Tomoko Kameyama (ep 7)Toshihiko Fukano (eps 1, 10)Wataru Nakagawa (ep 12)Xue Wen Xu (ep 9)Yasuyuki Suzuki (eps 1, 5, 8, 12)Yoshihiro Itō (ep 6)Yoshimi Imagawa (eps 3, 7, 10)Yoshiteru Kobayashi (ep 6)Yui Kusakabe (eps 1, 5, 10)Yuichi Akimoto (eps 2, 4, 7, 12)Yukie Kawakami (ep 6)Yukie Kinoshita (eps 2, 4, 8, 10)Yukiko Shimizu (ep 6)Yuko Matsuo (ep 6)Yūko Suzuki (eps 1, 3, 8)Yuri Abe (eps 1-2, 4)Literature: Aya SakaiMusic producer:Masakazu SatōMasao FukudaShun UchidaPhotography:Atsushi Satō (Studio Shamrock; eps 4-12)Hitomi Ōwatari (Studio Shamrock; eps 5, 7-12)Kōhei Suda (Studio Shamrock; eps 3-12)Minori Kimura (Studio Shamrock; eps 2-3, 6-12)Naoki Kurata (Studio Shamrock; eps 2-12)Tomokazu Nakanishi (Studio Shamrock; 9 episodeseps 2-5, 7, 9-12)Tsubasa Sato (Studio Shamrock; eps 1-3)Yusuke Sato (Studio Shamrock; eps 3-12)Planning:Asuka YamazakiKazuko IshikawaKōji HigashiguchiMitsugu IwanoNaokazu TsurutaRei Marumo (TV Tokyo)Shiro SasakiTakechika TsurutaniTatsuya MaedaToshiaki OkunoTsuneo TakechiWan Jing WangProduction Advancement:Ayaka Fujita (eps 4, 11)Maria Tomatsu (eps 1, 7)Ryōhei Yamada (eps 3, 10)Soma Anzai (ep 9)Takumi Katō (ep 6)Yuki Tobimoto (ep 4)Yuki Watanabe (eps 2, 8)Production Committee:Mitsuru ŌshimaRyōta KawamuraProduction Desk: Yuka MaekawaProgram Cooperation: Mayuko Oe (TV Tokyo)Prop Design: Shinobu OokawaPublicity:Asami ŌgiriHiroshi YamashitaKazuma WatanabeKeiko YonahaMika KonishiWyman JungPublicity Producer: Kazuo TsutsuiRecording Adjustment: Soichi TsunekawaRecording Assistant: Yuki IshiiSetting Production: Junji ItsukaichiSound Effects: Hiromune KurahashiSound Production Manager: Yoshiyuki OguriSp


About

Welcome to the group! You can connect with other members, ge...

Members

bottom of page